Navigation Links
TorreyPines Therapeutics to Host Webinar at 11 a.m. EDT Today on the Opportunity for Treating Chronic Pain, Migraine and Muscle Spasticity Through Inhibition of Neurotransmitter Glutamate
Date:6/25/2008

TorreyPines Therapeutics' CEO Neil Kurtz, M.D., to Moderate Discussion Following Presentations by Tony Yaksh, Ph.D.; Jerome Goldstein, M.D.; and

Alan J. Tuchman, M.D.

LA JOLLA, Calif., June 25 /PRNewswire/ -- A Webinar hosted by TorreyPines Therapeutics, Inc. (Nasdaq: TPTX) at 11 a.m. EDT on June 25 will bring together industry experts to discuss the opportunity of treating chronic pain, migraine and muscle spasticity through the inhibition of the neurotransmitter glutamate.

The company's President and Chief Executive Officer, Neil Kurtz, M.D., will moderate a discussion following brief presentations by:

-- Tony Yaksh, Ph.D., Professor and Vice Chairman for Research, Department of Anesthesiology, and Professor of Pharmacology at the University of California, San Diego

Dr. Yaksh will present information about glutamate receptors in the

central nervous system as a target for chronic pain therapy. The focus

of his research is the physiology and pharmacology of pain processing.

A member of numerous professional societies, Dr. Yaksh has been a

consultant to the U.S. Food and Drug Administration and serves on the

editorial boards of several journals. He has received many awards,

including the FWL Kerr Award from the American Pain Society and the

American Society of Anesthesiology Award for Excellence in Research.

-- Jerome Goldstein, M.D., Director of the San Francisco Headache Clinic and a board-certified neurologist who focuses on the diagnosis, treatment, prevention and cure of headache

Dr. Goldstein will present information about glutamate receptors in

the brain as a targ
'/>"/>

SOURCE TorreyPines Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
2. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
3. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
4. Tezampanel, TorreyPines Therapeutics Lead Compound, Reduced Muscle Spasticity and Rigidity in Preclinical Study Conducted at University of California, San Diego
5. Pharmacokinetic Data Suggest NGX426, TorreyPines Therapeutics Oral Prodrug of Tezampanel, May be Effective in Treating Acute Migraine Headache
6. Multiple Dose Clinical Trial of TorreyPines Therapeutics Tezampanel Demonstrates Compound is Safe and Well-Tolerated
7. TorreyPines Therapeutics Announces Strategic Plan with Focus on Clinical Development Activities to Maximize Value of Versatile Lead Compounds
8. TorreyPines Therapeutics Initiates Clinical Trial to Evaluate Analgesic Effect of Oral Prodrug of Tezampanel
9. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
10. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
11. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)...  TNI BioTech, Inc. (OTCQB: TNIB) ("TNIB" or ... development, marketing and distribution of opioid-related immunotherapies, announced ... with the Securities and Exchange Commission in connection ... be held on Thursday, September 4, 2014, at ... for determining those shareholders eligible to receive notice ...
(Date:7/28/2014)... -- ResMed (NYSE: RMD ), an innovator and ... breathing and other chronic respiratory conditions, has won a ... Taiwanese medical device manufacturer APEX Medical Corp. (APEX), prohibiting ... and 220 masks.  The judgment was entered by the ... is appealable, and applies throughout Germany.  ...
(Date:7/28/2014)... Minn. , July 28, 2014  ANI Pharmaceuticals, ... the Company plans to release its second quarter and ... before the opening of the U.S. financial markets. The ... Relations section of the Company,s website, www.anipharmaceuticals.com . ... Chief Executive Officer, and Charlotte C. Arnold , ...
Breaking Medicine Technology:TNI BioTech, Inc., Files Definitive Proxy Materials; Mails Letter Urging Shareholders to Vote the Proxy Card 2TNI BioTech, Inc., Files Definitive Proxy Materials; Mails Letter Urging Shareholders to Vote the Proxy Card 3ResMed Receives Permanent Injunction against APEX in Germany, Continues Enforcement of Patents in Europe 2ANI Pharmaceuticals Schedules Conference Call for Second Quarter 2014 Financial Results 2
(Date:7/29/2014)... Ticketability.com has reduced the cost of Phantom of ... lower prices on the secure website. Customers are invited to ... tickets that are priced lower every day. , Click ... Ticketability.com. , Theatergoers know that attending an entertaining show can ... the Opera tickets for sale that are priced to fit ...
(Date:7/28/2014)... Treat skin to a true cleansing with the ... and tomorrow only (while supplies last), take 40% off at ... for two specific users: , 1) those with oily skin ... and , 2) aging skin to help reduce lines, exfoliate ... of Sublime Beauty®. , Those with oily skin can use ...
(Date:7/28/2014)... 29, 2014 NAPW honors ... County Hospital Center, as a 2014 Professional Woman of ... distinction for leadership in community health. As the largest, ... virtually every industry and profession, the National Association of ... with over 600,000 members and nearly 300 Local Chapters. ...
(Date:7/28/2014)... La Mirada, CA (PRWEB) July 28, 2014 ... anyone seeking to pilot an airplane, helicopter, gyroplan or ... training. Those hoping to pilot balloons and gliders are ... purpose of the physical exam is to alert potential ... or prevent safe aviation. By detecting these conditions early, ...
(Date:7/28/2014)... “China Surgical Generators Market Outlook to ... Surgical Generators market. The report provides value, in ... average prices (in US dollars) within market segments ... Argon Plasma Coagulation Generators. , The report also ... each of these market categories, and global corporate-level ...
Breaking Medicine News(10 mins):Health News:Phantom of the Opera Tickets for Sale: Ticketability.com Delights Customers with Phantom of the Opera Theatre Tickets While Seats Last 2Health News:Clear, Clean Skin With the New Salicylic Wash from Sublime Beauty®; Enlivens Skin, Unclogs Pores 2Health News:National Association of Professional Women Announces Pamela A. Schulters, Head Nurse at Kings County Hospital Center, a 2014 Professional Woman of the Year 2Health News:Healthpointe Invites All Aspiring Pilots to Complete an FAA Certified Exam 2Health News:Key Market Data on China Surgical Generators Market to 2020 Report Available at MarketOptimizer.org 2Health News:Key Market Data on China Surgical Generators Market to 2020 Report Available at MarketOptimizer.org 3Health News:Key Market Data on China Surgical Generators Market to 2020 Report Available at MarketOptimizer.org 4
... SEATTLE, Aug. 5 On Thursday, August 6, 2009, ... Cell Therapeutics, Inc.,s (CTI) (Nasdaq and MTA: CTIC) management team will ... financial results. , , ... 8:30 a.m. Eastern/2:30 p.m. Central European/5:30 a.m. Pacific Time, ...
... , , ... , SILVER SPRING, Md., Aug. 5 For ... an Obesity Medicine Physician Certification (OMPC) Examination. The 18-month process of ... with an expected completion in March 2010. According to Dr. Robert ...
... , SAN FRANCISCO, Aug. 4 More ... Francisco Wednesday to protest gaps by California hospitals in safety preparation ... announced today. , , The nurses ... blew the whistle on unsafe patient care involving swine flu at ...
... , , ... ViroPharma Incorporated (Nasdaq: VPHM ... Committee supports the FDA,s Office of Generic Drugs (OGD) draft guidelines ... used to treat severe, often life-threatening bacterial infections of the gastrointestinal ...
... , , WASHINGTON, Aug. ... announced financial results for the first quarter of its fiscal year ending ... to $57.2 million in the first quarter of fiscal 2009. Net ... million, or $0.36 per diluted share, for the same period a year ...
... , EAST RUTHERFORD, N.J., Aug. 4 Cambrex Corporation ... 30, 2009. , , Highlights , , ... impact of foreign currency. Reported sales declined by 9.8% for the quarter. , ... in the same quarter last year (see attached table). , ...
Cached Medicine News:Health News:Ten Professional Societies Join Forces to Develop Obesity Medicine Certification Examination 2Health News:100+ Nurses to Rally in SF Wed. to Demand Stronger Swine Flu Safety Protections: California Hospitals Remain Unprepared Despite First Nurse Death 2Health News:100+ Nurses to Rally in SF Wed. to Demand Stronger Swine Flu Safety Protections: California Hospitals Remain Unprepared Despite First Nurse Death 3Health News:ViroPharma Announces Support by Advisory Committee of The Office of Generic Drugs Proposed Guidelines for Developing Generic Versions of Oral Vancomycin Hydorchloride 2Health News:ViroPharma Announces Support by Advisory Committee of The Office of Generic Drugs Proposed Guidelines for Developing Generic Versions of Oral Vancomycin Hydorchloride 3Health News:ViroPharma Announces Support by Advisory Committee of The Office of Generic Drugs Proposed Guidelines for Developing Generic Versions of Oral Vancomycin Hydorchloride 4Health News:The Advisory Board Company Reports Fiscal Year 2010 First Quarter Results 2Health News:The Advisory Board Company Reports Fiscal Year 2010 First Quarter Results 3Health News:The Advisory Board Company Reports Fiscal Year 2010 First Quarter Results 4Health News:The Advisory Board Company Reports Fiscal Year 2010 First Quarter Results 5Health News:The Advisory Board Company Reports Fiscal Year 2010 First Quarter Results 6Health News:The Advisory Board Company Reports Fiscal Year 2010 First Quarter Results 7Health News:The Advisory Board Company Reports Fiscal Year 2010 First Quarter Results 8Health News:The Advisory Board Company Reports Fiscal Year 2010 First Quarter Results 9Health News:The Advisory Board Company Reports Fiscal Year 2010 First Quarter Results 10Health News:The Advisory Board Company Reports Fiscal Year 2010 First Quarter Results 11Health News:The Advisory Board Company Reports Fiscal Year 2010 First Quarter Results 12Health News:Cambrex Reports Second Quarter 2009 Results 2Health News:Cambrex Reports Second Quarter 2009 Results 3Health News:Cambrex Reports Second Quarter 2009 Results 4Health News:Cambrex Reports Second Quarter 2009 Results 5Health News:Cambrex Reports Second Quarter 2009 Results 6Health News:Cambrex Reports Second Quarter 2009 Results 7Health News:Cambrex Reports Second Quarter 2009 Results 8Health News:Cambrex Reports Second Quarter 2009 Results 9Health News:Cambrex Reports Second Quarter 2009 Results 10Health News:Cambrex Reports Second Quarter 2009 Results 11Health News:Cambrex Reports Second Quarter 2009 Results 12
... consisting of 38 cobbs, osteotomes, elevators, ... spine. The instruments extra (15) length ... best applied in thoracic, lumbar and ... for surgeons to pick and choose ...
... growth factors (AGF) technology. Using ... AGF gel delivers a cocktail ... and proteins in high concentrations ... of new bone cells and ...
With the Leica D2D V3 video and photography system you can produce fantastic digital videos and pictures with the highest resolution....
... Headlight mounted micro video camera has been ... in areas otherwise invisible to all but ... The system may be used for all ... crowding of the sterile area and enabling ...
Medicine Products: